iGene™ has been validated prospectively on 146,958 cases, the world’s largest study of non invasive prenatal test to date.
Noninvasive Prenatal Testing for Trisomy 21, 18 and 13 - Clinical Experience from 146,958 Pregnancies.
Zhang H, et al. (2015) Ultrasound Obstet. & Gynecol. 10.1002/uog/14792.
Unlike other NIPTs, iGene™ test shows high sensitivity and specificity for T13Noninvasive fetal trisomy (NIFTY) test: An Advanced noninvasive prenatal diagnosis methodology for fetal autosomal and sex chromosomal aneuploidies.
Jiang F, et al, BMC Medical Genomics 2012 Dec:5.57 doc10.1186/1755-87945-57